2022-05-09T13:22:16-05:00 2021-06-30 521392008 GELMAN ROSENBERG & FREEDMAN 4550 MONTGOMERY AVE SUITE 800N BETHESDA MD 208142930 990 2020-07-01 237080568 AMERICAN SOCIETY OF HEMATOLOGY INC AMER 2027760544 2021 L STREET NW NO 900 WASHINGTON DC 20036 MARTHA LIGGETT EXECUTIVE DIRECTOR 2027760544 2022-05-09 1 MARTHA LIGGETT 999009999 RICHARD J LOCASTRO CPA P00288314 3019519090 2 AAL1 IAL1 2020 2022-09-23 18:48:47Z MARTHA LIGGETT 2021 L STREET NW NO 900 WASHINGTON DC 20036 132318414 0 X WWW.HEMATOLOGY.ORG X 1958 DC SEE PART III, LINE 1. 13 12 129 450 6120402 3565092 9177202 22988435 77357444 48884009 4255877 3371964 -191511 14089257 90599012 89333665 12096126 12495734 0 0 17749404 19844972 0 0 531545 45391847 38166194 75237377 70506900 15361635 18826765 269921032 322619681 85119119 90591088 184801913 232028593 X THE WORLD'S LARGEST PROFESSIONAL ORGANIZATION OF BLOOD SPECIALISTS, ASH AIMS TO FURTHER THE UNDERSTANDING, DIAGNOSIS, TREATMENT, AND PREVENTION OF DISORDERS AFFECTING THE BLOOD, BONE MARROW, AND THE IMMUNOLOGIC, HAEMOSTATIC AND VASCULAR SYSTEMS, BY PROMOTING RESEARCH, CLINICAL CARE, EDUCATION, TRAINING, AND ADVOCACY IN HEMATOLOGY. 0 0 18872054 1430226 1686753 PROJECTS AND MEMBER SERVICES: HELD TO BENEFIT OUR MEMBERS, OR THE HEMATOLOGY COMMUNITY AT-LARGE. EXAMPLES ARE: SMALL REGIONAL MEETINGS THAT HIGHLIGHT INFORMATION PRESENTED AT OUR ANNUAL MEETING, A DATABASE OF IMAGES THAT OUR MEMBERS CAN USE WHEN PRESENTING THEIR SCIENCE, AND OUR MONTHLY NEWSLETTERS. THE SOCIETY ALSO OFFERS A WIDE ARRAY OF EDUCATIONAL PRODUCTS AND SERVICES FOR CLINICIANS AND SCIENTISTS. 12884061 10250424 AWARDS: PROVIDED TO SUPPORT HEMATOLOGISTS IN ALL STAGES OF THEIR CAREERS AND TO HONOR THOSE WHO HAVE HELPED ADVANCE THE FIELD OF HEMATOLOGY. 11483128 87130 29789170 ANNUAL MEETING: PROVIDED A FORUM FOR THE DISCUSSION OF CRITICAL ISSUES IN HEMATOLOGY VIA EDUCATIONAL AND SCIENTIFIC SESSIONS, PLENARY SYMPOSIA, AND ABSTRACT PRESENTATIONS. SUPPORTED TRAINEES AND THOSE FROM DEVELOPING COUNTRIES WHO HAVE SUBMITTED ABSTRACTS FOR PRESENTATION. 8435949 641723 16342353 JOURNAL: PROVIDED AN INTERNATIONAL FORUM FOR THE PUBLICATION OF ORIGINAL ARTICLES DESCRIBING LABORATORY AND CLINICAL INVESTIGATIONS ENCOMPASSED IN THE FIELD OF HEMATOLOGY. 863476 86231 SMALL MEETINGS 3297653 LLC (FACILITY) 181836 1065733 CLINICAL NEWS 12778914 727954 17408086 56018157 1 1 0 1 0 0 0 0 0 1 1 1 0 1 1 1 0 1 0 0 1 0 1 0 1 0 0 1 1 1 0 0 0 0 0 0 0 1 0 0 0 0 1 1 1 0 0 0 1 323 0 1 129 1 1 1 0 0 0 0 0 0 0 0 0 0 0 X 13 12 0 0 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 1 0 0 AL AK AR CA FL GA HI IL KS KY ME MD MA MI MN MS ND NH NJ NM NY NC NV OH OK OR PA RI SC TN UT VA WA WI WV CT X TIFFANY AKE 2027760544 2021 L STREET NW SUITE 900 WASHINGTON DC 20036 X ROBERT A BRODSKY SECRETARY THEN VP (EFF. 01/21) 2.00 2.00 X X 12423 0 0 STEPHANIE LEE PRESIDENT (THROUGH 12/20) 2.00 2.00 X X 11205 0 0 JOSEPH MIKHAEL COUNCILLOR 2.00 2.00 X 9000 0 0 MARTIN S TALLMAN PRES.-ELECT THEN PRES. (EFF. 01/21) 2.00 2.00 X X 1000 0 0 JANE N WINTER VP THEN PRESIDENT-ELECT (EFF. 01/21) 2.00 2.00 X X 0 0 0 MARK CROWTHER TREASURER 2.00 2.00 X X 0 0 0 CYNTHIA E DUNBAR COUNCILLOR THEN SEC. (EFF. 01/21) 2.00 2.00 X X 0 0 0 BETTY PACE COUNCILLOR (BEG. 01/21) 2.00 2.00 X 0 0 0 ARNOLD GANSER COUNCILLOR 2.00 2.00 X 0 0 0 JOHN C BYRD COUNCILLOR (THROUGH 12/20) 2.00 2.00 X 0 0 0 AGNES LEE COUNCILLOR 2.00 2.00 X 0 0 0 BELINDA AVALOS COUNCILLOR 2.00 2.00 X 0 0 0 BOB LOWENBERG COUNCILLOR 2.00 2.00 X 0 0 0 ALLISON LOREN COUNCILLOR 2.00 2.00 X 0 0 0 JAMILE M SHAMMO COUNCILLOR (BEG. 01/21) 2.00 2.00 X 0 0 0 MARTHA LIGGETT EXECUTIVE DIRECTOR 35.00 X 730843 0 54318 MATTHEW GERTZOG DEPUTY EXECUTIVE DIRECTOR 17.00 18.00 X 504996 0 54954 NINA HOFFMAN CHIEF PUBLICATIONS OFFICER 35.00 X 389353 0 55643 ROBERT PLOVNICK CHIEF MEDICAL QUALITY OFFICER 17.00 18.00 X 399105 0 54025 KARINA FERNANDEZ CHIEF INFORMATION OFFICER 35.00 X 358428 0 48567 CHARLES CLAYTON CHIEF PROF. DEV & DIVERSITY OFFICER 35.00 X 355726 0 39476 WILLIAM REED CHIEF EVENT STRATEGY OFFICER 35.00 X 390047 0 38921 3162126 0 345904 54 0 1 0 FREEMAN PO BOX 734596 DALLAS TX 753734596 ASH MEETINGS DECORATOR 3469227 SPARGO INC 11208 WAPLES MILL RD FAIRFAX VA 22030 ANNUAL MEETING CONSULTANTS 3443973 GEEKHIVE 28 CHURCH STREET STE 2A WARWICK NY 10990 IT CONSULTING 2766917 DARTMOUTH JOURNAL SERVICES PO BOX 419817 BOSTON MA 022419817 JOURNAL PRINTING 1874327 PHARMACEUTICAL MEDIA INC MURRAY HILL STATION PO BOX 1332 NEW YORK NY 10156 ADVERTISEMENT CONSULTANT 1061511 44 4051230 14000 966840 17956365 22988435 ANNUAL MEETING 900099 29789170 29789170 BLOOD JOURNAL 900099 11088237 11088237 ADVERTISING 541800 5254116 180075 5074041 PROJECTS 900099 1507613 1507613 CLINICAL NEWS 541800 1065733 1065733 179140 179140 48884009 1339990 1339990 13623810 13623810 1333800 1557536 -223736 -223736 -198512 -25224 43447367 41415393 2031974 2031974 2031974 37690 14000 11820 25870 25870 COST AGREEMENT 900099 460505 460505 UNEARNED INCOME 900099 200069 200069 MISCELLANEOUS 900099 2739 2739 663313 89333665 42565095 6120402 17659733 X 764647 764647 9880500 9880500 1850587 1850587 1106431 527319 526465 52647 13596749 9880469 3494040 222240 1282551 921646 338600 22305 2859140 2038740 768751 51649 1000101 709452 272136 18513 1438398 719199 719199 103616 103616 223250 223250 159000 159000 9327107 4768216 4486684 72207 1389915 1390953 -1988 950 1461200 931397 525066 4737 2625030 1341830 1283200 223801 -377060 550789 50072 9248570 9173267 75303 1134053 1134053 2158349 1902468 232518 23363 87385 63526 22415 1444 UBI TAX 1172230 1172230 PUBLICATIONS 3030153 3029505 648 OTHER TAXES AND FEES 455176 455176 MAINTENANCE & OVERHEAD 371416 371416 3557545 3145371 400756 11418 70506900 56018157 13957198 531545 5473253 13085865 27775012 23900870 1290455 382878 5455117 7499534 3152299 2311663 76374679 20387995 57425041 55986684 132900578 157487202 22658107 41009926 13791170 20955059 269921032 322619681 9184289 13413423 8952102 8783020 20314051 20664859 33701521 12847845 47610475 119311 119311 85119119 90591088 X 174469390 218130270 10332523 13898323 184801913 232028593 269921032 322619681 18826765 28399915 0 X 0 1 X 1 1 1 X 8856468 12895284 11589430 9177202 22988435 65506819 49533695 54499108 63147400 69617027 42565095 279362325 58390163 67394392 74736830 78794229 65553530 344869144 36574 76336 57829 30755 31447 232941 5994017 5239682 8701078 7577730 8515946 36028453 6030591 5316018 8758907 7608485 8547393 36261394 308607750 3403959 2858145 3069988 3376219 15106799 27815110 3403959 2858145 3069988 3376219 15106799 27815110 2500964 3676028 4646049 4554668 3392449 18770158 -5817 74401 26618 -67767 663313 690748 64289269 74002966 82479485 86657349 84716091 392145160 0.78700 0.81860 0.07090 0.04750 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 13459 250583 264042 70242858 70506900 1000000 250000 0 0 1000000 1000000 1000000 1000000 4000000 6000000 278864 257275 244222 264042 1044403 250000 250000 250000 250000 1000000 1500000 8991 11943 6987 13459 41380 8036590 1729768 489601 9276757 8607385 -424174 146621 8036590 8554929 375838 323382 8607385 8210270 578396 233737 8554929 7457742 887719 135191 8210270 0.00000 0.79380 0.20620 0 0 12458802 12458802 54003999 14860778 39143221 3104905 1763902 1341003 6806973 3763315 3043658 55986684 COMMINGLED UNITIZED POOLS 6288443 F HEDGE FUND - WEATHERLOW OFFSHORE FUND I LTD 6989583 F UNALLOCATED INSURANCE CONTRACTS 678266 F LIMITED PARTNERSHIP 10743226 F GEM OPPORTUNITIES FUND 1949022 F BURGUNDY FUNDS DST SMALLER COMPANIES PORTFOLIO 4979917 F ARROWSTREET INTERNATIONAL EQUITY FUND 9381469 F 41009926 BROKER FEES 46998 SUBLEASE RECEIVABLE 139858 DUE FROM RELATED PARTY 20768203 20955059 TENANT SECURITY DEPOSIT 119311 119311 X 119824177 28399915 2237777 30637692 89186485 159000 -11820 147180 89333665 78874134 8514414 8514414 70359720 159000 -11820 147180 70506900 PART V, LINE 4: THE ENDOWMENT FUNDS SUPPORT THE FOLLOWING PROGRAMS, AS SPECIFIED BY DONORS: ASH SCHOLAR AWARDS, THE CLINICAL RESEARCH TRAINING INSTITUTE, THE GIBSON AWARD, THE LEVY AWARD, AND THE COULTER AWARD. PART X, LINE 2: FOR THE YEARS ENDED JUNE 30, 2021 AND 2020, THE SOCIETY HAS DOCUMENTED ITS CONSIDERATION OF FASB ASC 740-10, INCOME TAXES, THAT PROVIDES GUIDANCE FOR REPORTING UNCERTAINTY IN INCOME TAXES AND HAS DETERMINED THAT NO MATERIAL UNCERTAIN TAX POSITIONS QUALIFY FOR EITHER RECOGNITION OR DISCLOSURE IN THE CONSOLIDATED FINANCIAL STATEMENTS. PART XI, LINE 2D - OTHER ADJUSTMENTS: RENTAL EXPENSE INCLUDED AS EXPENSE ON THE AUDIT AND NETTED 1,557,536. AGAINST REVENUE ON FORM 990, PART VIII, LINE 6C. ASH REGISTRY REVENUE, INCLUDED IN THE CONSOLIDATED 1,111,574. AUDIT REPORT AND EXCLUDED FROM ASH, INC. FORM 990 REPORTING. ELIMINATIONS INCLUDED IN THE CONSOLIDATED AUDIT REPORT -431,333. AND EXCLUDED FROM ASH, INC. FORM 990 REPORTING. PART XI, LINE 4B - OTHER ADJUSTMENTS: FUNDRAISING EVENT EXPENSES REPORTED AS EXPENSE ON THE AUDIT -11,820. AND NETTED AGAINST REVENUE ON FORM 990, PART VIII, LINE 8C. PART XII, LINE 2D - OTHER ADJUSTMENTS: RENTAL EXPENSE INCLUDED AS EXPENSE ON THE AUDIT AND NETTED 1,557,536. AGAINST REVENUE ON FORM 990, PART VIII, LINE 6C. ASH REGISTRY EXPENSES, INCLUDED IN THE CONSOLIDATED 7,388,211. AUDIT REPORT AND EXCLUDED FROM ASH, INC. FORM 990 REPORTING. ELIMINATIONS INCLUDED IN THE CONSOLIDATED AUDIT REPORT -431,333. AND EXCLUDED FROM ASH, INC. FORM 990 REPORTING. PART XII, LINE 4B - OTHER ADJUSTMENTS: FUNDRAISING EVENT EXPENSES REPORTED AS EXPENSE ON THE AUDIT -11,820. AND NETTED AGAINST REVENUE ON FORM 990, PART VIII, LINE 8C. 1 CENTRAL AMERICA AND THE CARIBBEAN 0 0 BOOK VALUE OF INVESTMENTS IN THE REGION 6989583 EAST ASIA AND THE PACIFIC 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 486000 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 524600 NORTH AMERICA 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 453987 SOUTH AMERICA 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 86000 SOUTH ASIA 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 150000 SUB-SAHARAN AFRICA 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 150000 0 0 0 0 0 0 8840170 0 8840170 ASH AWARD SUPPLEMENT EAST ASIA AND THE PACIFIC 2 30000 WIRE ASH-JSH ABSTRACT ACHIEVEMENT AWARD EAST ASIA AND THE PACIFIC 3 6000 WIRE GLOBAL RESEARCH AWARD EAST ASIA AND THE PACIFIC 3 450000 WIRE ASH AWARD SUPPLEMENT EUROPE (INCLUDING ICELAND & GREENLAND) 4 170000 WIRE ASH-BSH ABSTRACT ACHIEVEMENT AWARD EUROPE (INCLUDING ICELAND & GREENLAND) 3 6000 WIRE GLOBAL RESEARCH AWARD EUROPE (INCLUDING ICELAND & GREENLAND) 2 298600 WIRE RESEARCH RESTART EUROPE (INCLUDING ICELAND & GREENLAND) 1 50000 WIRE ASH AWARD SUPPLEMENT NORTH AMERICA 1 40000 WIRE GLOBAL RESEARCH AWARD NORTH AMERICA 2 288987 WIRE SCHOLAR AWARD NORTH AMERICA 1 125000 WIRE ASH AWARD SUPPLEMENT SOUTH AMERICA 1 20000 WIRE GLOBAL RESEARCH AWARD SOUTH AMERICA 1 66000 WIRE GLOBAL RESEARCH AWARD SOUTH ASIA 1 150000 WIRE ASH AWARD SUPPLEMENT SUB-SAHARAN AFRICA 3 150000 WIRE 0 0 0 1 0 0 PART I, LINE 2: THE AMERICAN SOCIETY OF HEMATOLOGY (ASH) HAS MANY AWARD PROGRAMS THAT ARE AVAILABLE TO INDIVIDUALS OUTSIDE THE UNITED STATES, AND AS A RESULT, OUR PROCEDURES TO MONITOR GRANTS OUTSIDE THE U.S. VARY BY THE GRANT PROGRAM. IN GENERAL, PARTICIPANTS MUST SUBMIT A LETTER FROM A MENTOR, DEPARTMENT HEAD, OR DIVISION CHIEF AFFIRMING THAT PROGRESS IS BEING MADE AT THE END OF EACH YEAR OF MULTIYEAR PROJECTS. AT AWARD COMPLETION, THE PARTICIPANT SUBMITS REQUIRED EVALUATION FORMS THAT PROVIDE THE SOCIETY WITH UPDATES ON PARTICIPANTS' PROGRESS DURING THE AWARD PERIOD. IN ADDITION TO THE EVALUATIONS, AWARDEES PARTICIPATING IN RESEARCH-BASED PROGRAMS ARE REQUIRED TO SUBMIT A FINAL RESEARCH SUMMARY REPORT AND A FINAL FINANCIAL REPORT, DETAILING HOW THE FUNDS WERE USED. THE FINAL PROGRESS REPORT AND FINANCIAL REPORT MUST BE SUBMITTED WITHIN 60 DAYS AFTER THE COMPLETION OF THE PROJECT. ANY UNUSED FUNDS MUST BE RETURNED TO ASH AT THE TIME THE FINANCIAL REPORT IS SUBMITTED. PARTICIPANTS AND THEIR INSTITUTIONS ARE MADE AWARE OF ASH'S REGULATIONS AT THE TIME THE AWARD IS ACCEPTED. FOR THOSE THAT DO NOT COMPLY WITH THE RULES, ASH RESERVES THE RIGHT TO WITHHOLD REMAINING FUNDS AND/OR TEMPORARILY SUSPEND THE INSTITUTION FROM RECEIVING OTHER GRANTS THE SOCIETY OFFERS UNTIL THE INSTITUTION IS IN GOOD STANDING. PART III ACCOUNTING METHOD: WALK/RUN 51690 14000 37690 11820 51690 14000 37690 11820 11820 25870 1 ASH REGISTRY INC 2021 L STREET NW SUITE 900 WASHINGTON DC 20036 824218205 501(C)(3) 431333 SUBRECIPIENT AWARD - PROGRAM SUPPORT CHILDREN'S HOSPITAL MEDICAL CENTER 3333 BURNET AVE CINCINNATI OH 452293026 310833936 501(C)(3) 333314 SUBRECIPIENT AWARD - PROGRAM SUPPORT 2 0 ASH AWARD SUPPLEMENT 8 330000 BRIDGE GRANTS 9 1350000 ERNEST BEUTLER LECTURE AND PRIZE 2 15000 MINORITY GRADUATE STUDENT ABSTRACT ACHIEVEMENT AWARD 5 7500 MINORITY HEMATOLOGY FELLOW AWARD 5 500000 MINORITY HEMATOLOGY GRADUATE AWARD 4 480000 MINORITY MEDICAL STUDENT AWARD (MMSAP) 16 173000 PHYSICIAN SCIENTIST CAREER DEVELOPMENT AWARD 6 252000 RESEARCH RESTART 18 870000 RESEARCH TRAINING AWARD FOR FELLOWS 17 1190000 SCHOLAR AWARDS 35 4475000 WALTER H. COULTER AWARD 1 10000 HONORS AWARDS 37 185000 MINORITY RESIDENT HEMATOLOGY AWARD 7 35000 OUTSTANDING ABSTRACT ACHIEVEMENT AWARD 4 8000 PART I, LINE 2: IN GENERAL, GRANTEES MUST COMPLETE A FIRST YEAR EVALUATION FORM AND AN AWARD COMPLETION EVALUATION FORM THAT PROVIDES THE SOCIETY WITH UPDATES ON PARTICIPANTS' PROGRESS DURING THE AWARD PERIOD. IN ADDITION TO THE EVALUATIONS, PARTICIPANTS ARE ALSO REQUIRED TO SUBMIT A FINAL RESEARCH SUMMARY REPORT AND A FINAL FINANCIAL REPORT, ON INSTITUTION LETTERHEAD, DETAILING HOW THE FUNDS WERE USED. THE FINAL PROGRESS REPORT AND FINANCIAL REPORT MUST BE SUBMITTED WITHIN 60 DAYS AFTER THE COMPLETION OF THE PROJECT. ANY UNUSED FUNDS MUST BE RETURNED TO ASH AT THE TIME THAT THE FINANCIAL REPORT IS SUBMITTED. GRANTEES AND THEIR INSTITUTIONS ARE MADE AWARE OF ASH'S REGULATIONS AT THE TIME THE AWARD IS ACCEPTED. FOR THOSE THAT DO NOT COMPLY WITH THE RULES, ASH RESERVES THE RIGHT TO WITHHOLD THE REMAINING FUNDS AND/OR TEMPORARILY SUSPEND THE GRANTEE FROM RECEIVING OTHER GRANTS THE SOCIETY OFFERS UNTIL THE GRANTEE IS IN GOOD STANDING. X X 1 1 X X X X X 0 0 0 0 0 0 0 1 0 MARTHA LIGGETT EXECUTIVE DIRECTOR 648371 0 82472 0 0 0 27864 0 26454 0 785161 0 0 0 MATTHEW GERTZOG DEPUTY EXECUTIVE DIRECTOR 467612 0 37384 0 0 0 28500 0 26454 0 559950 0 0 0 ROBERT PLOVNICK CHIEF MEDICAL QUALITY OFFICER 394105 0 5000 0 0 0 26821 0 27204 0 453130 0 0 0 NINA HOFFMAN CHIEF PUBLICATIONS OFFICER 361853 0 27500 0 0 0 28439 0 27204 0 444996 0 0 0 WILLIAM REED CHIEF EVENT STRATEGY OFFICER 362547 0 27500 0 0 0 28439 0 10482 0 428968 0 0 0 KARINA FERNANDEZ CHIEF INFORMATION OFFICER 358428 0 0 0 0 0 28443 0 20124 0 406995 0 0 0 CHARLES CLAYTON CHIEF PROF. DEV & DIVERSITY OFFICER 355726 0 0 0 0 0 28472 0 11004 0 395202 0 0 0 PART I, LINE 1A THE ORGANIZATION'S BENEFIT PACKAGE INCLUDES PROVISIONS FOR HEALTH CLUB DUES AND A WELLNESS PLAN FOR ALL EMPLOYEES UP TO $750 PER EMPLOYEE AND CALENDAR YEAR. ASH PROVIDES GROSS-UP STIPENDS TO OFFICERS ALONG WITH THE EDITORS OF ITS BLOOD JOURNAL. PART I, LINE 7 BONUS COMPENSATION HAS BEEN REFLECTED IN PART II, COLUMN (B)(II). SUBSTANTIAL CONTRIBUTOR SUBSTANTIAL CONTRIBUTOR 100424 SEE PART V -"SUBSTANTIAL CONTRIBUTOR" REPORTED A CONTRIBUTION OF $18,000 ON SCHEDULE B, WHICH MAKES THE COMPANY "AN INTERESTED PERSON" FOR SCHEDULE L REPORTING PURPOSES. IN ADDITION TO ITS CONTRIBUTION, THIS COMPANY PAID FOR EXHIBITS, REGISTRATION, AND OTHER MISCELLANEOUS ITEMS FOR A TOTAL OF $100,424, WHICH IS WITHIN THE SAME PRICE RANGE THAT ALL OTHER COMPANIES PAID FOR THESE TYPES OF TRANSACTIONS. 0 SUBSTANTIAL CONTRIBUTOR SUBSTANTIAL CONTRIBUTOR 181200 SEE PART V -"SUBSTANTIAL CONTRIBUTOR" REPORTED A CONTRIBUTION IN THE AMOUNT OF $1,344,713 ON SCHEDULE B, WHICH MAKES THE COMPANY "AN INTERESTED PERSON" FOR SCHEDULE L REPORTING PURPOSES. IN ADDITION TO THE CONTRIBUTION, THIS COMPANY PAID FOR MEMBERSHIP AND EXHIBITS FOR $181,200, WHICH IS WITHIN THE SAME PRICE RANGE THAT ALL OTHER COMPANIES PAID FOR THESE TYPES OF TRANSACTIONS. 0 SUBSTANTIAL CONTRIBUTOR SUBSTANTIAL CONTRIBUTOR 101863 SEE PART V -"SUBSTANTIAL CONTRIBUTOR" REPORTED A CONTRIBUTION IN THE AMOUNT OF $176,350 ON SCHEDULE B, WHICH MAKES THE COMPANY "AN INTERESTED PERSON" FOR SCHEDULE L REPORTING PURPOSES. IN ADDITION TO THE CONTRIBUTION, THIS COMPANY PAID FOR MEMBERSHIP, REGISTRATION, EXHIBITS AND MISCELLANEOUS ITEMS FOR $101,863, WHICH IS WITHIN THE SAME PRICE RANGE THAT ALL OTHER COMPANIES PAID FOR THESE TYPES OF TRANSACTIONS. 0 SUBSTANTIAL CONTRIBUTOR SUBSTANTIAL CONTRIBUTOR 248725 SEE PART V -"SUBSTANTIAL CONTRIBUTOR" REPORTED A CONTRIBUTION IN THE AMOUNT OF $886,450 ON SCHEDULE B, WHICH MAKES THE COMPANY "AN INTERESTED PERSON" FOR SCHEDULE L REPORTING PURPOSES. IN ADDITION TO THE CONTRIBUTION, THIS COMPANY PAID FOR MEMBERSHIP, EXHIBITS AND MISCELLANEOUS ITEMS FOR $248,725, WHICH IS WITHIN THE SAME PRICE RANGE THAT ALL OTHER COMPANIES PAID FOR THESE TYPES OF TRANSACTIONS. 0 SUBSTANTIAL CONTRIBUTOR SUBSTANTIAL CONTRIBUTOR 2758000 SEE PART V -"SUBSTANTIAL CONTRIBUTOR" REPORTED A CONTRIBUTION IN THE AMOUNT OF $30,000 ON SCHEDULE B, WHICH MAKES THE COMPANY "AN INTERESTED PERSON" FOR SCHEDULE L REPORTING PURPOSES. IN ADDITION TO THE CONTRIBUTION, THIS COMPANY PAID FOR MEETINGS AND MISCELLANEOUS ITEMS FOR $2,758,000, WHICH IS WITHIN THE SAME PRICE RANGE THAT ALL OTHER COMPANIES PAID FOR THESE TYPES OF TRANSACTIONS. 0 SUBSTANTIAL CONTRIBUTOR SUBSTANTIAL CONTRIBUTOR 907200 SEE PART V -"SUBSTANTIAL CONTRIBUTOR" REPORTED A CONTRIBUTION IN THE AMOUNT OF $1,917,900 ON SCHEDULE B, WHICH MAKES THE COMPANY "AN INTERESTED PERSON" FOR SCHEDULE L REPORTING PURPOSES. IN ADDITION TO THE CONTRIBUTION, THIS COMPANY PAID FOR ADVERTISING AND EXHIBITS FOR $907,200, WHICH IS WITHIN THE SAME PRICE RANGE THAT ALL OTHER COMPANIES PAID FOR THESE TYPES OF TRANSACTIONS. 0 SUBSTANTIAL CONTRIBUTOR SUBSTANTIAL CONTRIBUTOR 443056 SEE PART V -"SUBSTANTIAL CONTRIBUTOR" REPORTED A CONTRIBUTION OF $117,500 ON SCHEDULE B, WHICH MAKES THE COMPANY "AN INTERESTED PERSON" FOR SCHEDULE L REPORTING PURPOSES. IN ADDITION TO ITS CONTRIBUTION, THIS COMPANY PAID FOR REGISTRATION AND ADVERTISING FOR A TOTAL OF $443,056, WHICH IS WITHIN THE SAME PRICE RANGE THAT ALL OTHER COMPANIES PAID FOR THESE TYPES OF TRANSACTIONS. 0 SUBSTANTIAL CONTRIBUTOR SUBSTANTIAL CONTRIBUTOR 117695 SEE PART V -"SUBSTANTIAL CONTRIBUTOR" REPORTED A CONTRIBUTION OF $25,000 ON SCHEDULE B, WHICH MAKES THE COMPANY "AN INTERESTED PERSON" FOR SCHEDULE L REPORTING PURPOSES. IN ADDITION TO ITS CONTRIBUTION, THIS COMPANY PAID FOR ADVERTISING, REGISTRATION AND MISCELLANEOUS ITEMS FOR A TOTAL OF $117,695 WHICH IS WITHIN THE SAME PRICE RANGE THAT ALL OTHER COMPANIES PAID FOR THESE TYPES OF TRANSACTIONS. 0 SUBSTANTIAL CONTRIBUTOR SUBSTANTIAL CONTRIBUTOR 494009 SEE PART V -"SUBSTANTIAL CONTRIBUTOR" REPORTED A CONTRIBUTION OF $622,500 ON SCHEDULE B, WHICH MAKES THE COMPANY "AN INTERESTED PERSON" FOR SCHEDULE L REPORTING PURPOSES. IN ADDITION TO ITS CONTRIBUTION, THIS COMPANY PAID FOR ADVERTISING, SUBSCRIPTIONS, EXHIBITS AND REGISTRATION FOR A TOTAL OF $494,009 WHICH IS WITHIN THE SAME PRICE RANGE THAT ALL OTHER COMPANIES PAID FOR THESE TYPES OF TRANSACTIONS. 0 FORM 990, PART VI, SECTION A, LINE 6 THE AMERICAN SOCIETY OF HEMATOLOGY HAS INDIVIDUAL MEMBERS. FORM 990, PART VI, SECTION A, LINE 7A THE AMERICAN SOCIETY OF HEMATOLOGY HAS AN INDIVIDUAL MEMBERSHIP THAT HAS THE AUTHORITY TO ELECT THE MEMBERS OF THE EXECUTIVE COMMITTEE OF THE GOVERNING BOARD. FORM 990, PART VI, SECTION A, LINE 7B THE AMERICAN SOCIETY OF HEMATOLOGY'S MEMBERSHIP HAS THE RIGHT TO VOTE ON CHANGES TO ITS BYLAWS. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 WAS PREPARED BY THE OUTSIDE ACCOUNTANTS AND REVIEWED FIRST BY THE SENIOR ACCOUNTANT AND THE DEPUTY DIRECTOR OF FINANCE, THEN BY THE CHIEF FINANCIAL OFFICER, AND THEN BY THE EXECUTIVE DIRECTOR. IT IS THEN SENT TO THE ENTIRE BOARD PRIOR TO FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C AMERICAN SOCIETY OF HEMATOLOGY'S CONFLICT OF INTEREST POLICY QUESTIONNAIRE IS FILLED OUT ELECTRONICALLY BY ALL BOARD MEMBERS AND EMPLOYEES. BEFORE EACH BOARD OR COMMITTEE MEETING A MEMBER IS PUT IN CHARGE OF REVIEWING ALL CONFLICT OF INTEREST STATEMENTS FOR THE MEMBERS ATTENDING. FURTHERMORE, MEMBERS ARE ASKED TO DISCLOSE ANY CHANGES BEFORE EVERY MEETING. WHEN AN ASH MEMBER HAS A CONFLICT, S/HE WILL NOT: 1. TAKE ANY ACTION ON BEHALF OF ASH CONCERNING THE SUBJECT IN CONFLICT OR ANY ISSUE RELEVANT TO THE SUBJECT IN CONFLICT; 2. PARTICIPATE IN DISCUSSIONS ON THE SUBJECT WITHOUT FULL DISCLOSURE; 3. PARTICIPATE IN DECISION-MAKING DISCUSSIONS OR CAST A VOTE; 4. IMPLY THAT HE/SHE IS ACTING ON BEHALF OF ASH WHEN DISCUSSING THE RELEVANT SUBJECT WITH THIRD PARTIES; OR 5. FAIL TO CLARIFY WITH THIRD PARTIES WITH WHOM HE/SHE DEALS ON THE RELEVANT SUBJECT THAT HE/SHE IS NOT ACTING ON BEHALF OF ASH. FORM 990, PART VI, SECTION B, LINE 15A TO ATTRACT AND RETAIN STELLAR TALENT IN THIS TOP EXECUTIVE POSITION, ASH PERIODICALLY ASSESSES MARKET SALARY TRENDS FOR THIS ROLE. THIS INCLUDES A COMPREHENSIVE MARKET SALARY REVIEW CONDUCTED BY NONPROFIT HR SOLUTIONS (NPHRS) AND ASSOCIATION STRATEGIES, INC. EVERY THREE YEARS. THIS BENCHMARKING INCLUDES AN ASSESSMENT OF SALARIES AND BENEFITS OF OTHER NON-PROFIT MEDICAL ASSOCIATION CHIEF EXECUTIVES WITH COMPARABLE BUDGET, STAFF SIZE, AND MISSION. WITH THE RESULTS OF THIS DATA, ASH CONSIDERS THE PERFORMANCE OF THE EXECUTIVE DIRECTOR, AND SETS A SALARY ALIGNED AT LEAST WITH THE MEAN OF THE MARKET. EXECUTIVE COMPENSATION FOR THE EXECUTIVE DIRECTOR IS ESTABLISHED BY CONTRACT BETWEEN THE BOARD OF DIRECTORS AND THE EXECUTIVE DIRECTOR WHICH IS TYPICALLY RENEGOTIATED EVERY THREE YEARS. EXECUTIVE COMPENSATION FOR THE EXECUTIVE DIRECTOR IS DETERMINED BY THE BOARD OF DIRECTORS AND CONFIRMED IN A FULLY EXECUTED CONTRACT SIGNED BY THE PRESIDENT AND THE EXECUTIVE DIRECTOR. THE LAST SALARY REVIEW WAS DONE IN NOVEMBER 2021. THE COMPENSATION FOR THE OTHER OFFICERS OR KEY EMPLOYEES OF THE ORGANIZATION IS REVIEWED BY AN OUTSIDE HR GROUP AND APPROVED BY THE EXECUTIVE DIRECTOR. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS AND FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. THE CONFLICT OF INTEREST POLICY IS LOCATED ON THE ORGANIZATION'S WEBSITE. PART VII, SECTION A - COMPENSATION OF BOARD MEMBERS: BOARD MEMBERS MAY RECEIVE COMPENSATION RELATED TO SPEAKING ENGAGEMENTS OR WRITING ARTICLES FOR THE SOCIETY. FORM 990, PART IX, LINE 11G CONSULTING FEES: PROGRAM SERVICE EXPENSES 2,440,216. MANAGEMENT AND GENERAL EXPENSES 4,468,238. FUNDRAISING EXPENSES 72,207. TOTAL EXPENSES 6,980,661. HONORARIUM: PROGRAM SERVICE EXPENSES 2,328,000. MANAGEMENT AND GENERAL EXPENSES 18,446. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 2,346,446. FORM 990, PART IV, QUESTION 28C: IN 2020, ASH HAD BUSINESS TRANSACTIONS WITH ENTITIES THAT MEET THE IRS DEFINITION OF AN INTERESTED PERSON (SUBSTANTIAL CONTRIBUTOR) AS SPECIFIED IN THE FORM 990, SCHEDULE L, PART IV INSTRUCTIONS. THEREFORE, IN ACCORDANCE WITH THE IRS INSTRUCTIONS, ASH IS FILING A SCHEDULE L TO REPORT BUSINESS TRANSACTIONS WITH INTERESTED PARTIES. PART IV, QUESTION 28 DOES NOT INCLUDE TRANSACTIONS INVOLVING INTERESTED PERSONS AS DEFINED IN SCHEDULE L. ALTHOUGH QUESTION 28 DOES NOT INCLUDE "INTERESTED PERSONS", ASH HAS ANSWERED "YES" TO QUESTION 28C TO NOTE THE FILING OF SCHEDULE L. ASH DID NOT HAVE A 2020 BUSINESS TRANSACTION WITH ANY ENTITY OF WHICH A CURRENT OR FORMER OFFICER, DIRECTOR, TRUSTEE, OR KEY EMPLOYEE (OR A FAMILY MEMBER THEREOF) WAS AN OFFICER, DIRECTOR, TRUSTEE, OR DIRECT OR INDIRECT OWNER. ASH 2021 L LLC 2021 L STREET NW NO 900 WASHINGTON DC 20036 263243051 TO OWN ASH'S PRINCIPAL PROPERTY DC 1299355 65760416 N/A ASH REGISTRY INC 2021 L STREET NW NO 900 WASHINGTON DC 20036 824218205 TO FOSTER COLLABORATIVE PARTNERSHIPS TO ACCELERATE PROGRESS IN HEMATOLOGY DC 501(C)(3) LINE 12B, II ASH 1 0 1 0 1 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 ASH REGISTRY INC D 21075918 ACTUAL AMOUNT ASH REGISTRY INC B 431333 ACTUAL AMOUNT ASH REGISTRY INC N 980000 COSTSHARING AGREEEMENT ASH REGISTRY INC O 0 COST SHARING AGREEMENT ASH REGISTRY INC P 0 COST SHARING AGREEMENT